NCT00230308Recruiting
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 28 Sept 2005
- Start date
- 2 Apr 2002
- Primary completion date
- Jun 2030
- Lead sponsor
- Stanford University
- Diseases
- Head and neck cancer
- NCT number
- NCT00230308
What you commit to
- Study type: Observational
- Planned participants: 500
- From 2 Apr 2002 to the primary completion date, Jun 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-Stanford patients.
Who the study is looking for
- All patients undergoing surgery at Stanford University for head and neck cancer.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University School of Medicine Coordinator of this site? Confirm its status | Stanford | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.